OBJECTIVE： To provide reference for strengthening the supervision and management of responsibility of pharmaceutical corporates in China. METHODS： The status quo of social responsibility of pharmaceutical corporates in China were an- alyzed， and international experience of the United States， European countries and so on were analyzed. The ways to enhance the social responsibility of pharmaceutical corporates in China were proposed. RESULTS & CONCLUSIONS： Since the corporate social responsibility was first written into the People’s Republic of China Company Law in 2005， the Chinese government has attached great importance to the implement of corporate social responsibility； however， the social responsibility of pharmaceutical corporates in China is still in the initial stage and lags behind other industries. The United States promotes corporate social responsibility through the formulation of perfect medical policies and regulations， non-governmental organizations participating in supervision， and the establishment of a sound financial incentive mechanism； Government in Germany， Britain and other European countries play an important role in promoting corporate social responsibility； at the same time， perfect supervision system of civil society is an important driving force to promote corporate social responsibility. When promoting the social responsibility of pharmaceutical co- rporates in China， it is necessary to improve the awareness of social responsibility of pharmaceutical enterprises through multiple paths， such as giving full play the supervision and management role of government， strengthening public supervision and management function， strengthening the system construction of social financial responsibility， improving the awareness of responsibility of pharmaceutical corporates.